The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
NCT00346190
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Alendronate
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators
[object Object]